Olympiad Research’s Idexx Laboratories IDXX Stock Holding History

Olympiad Research’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-542	Closed	-$228K	–	234
2025 Q1	$228K	Buy	542 +36	+7%	+$15.6K	0.27%	149
2024 Q4	$209K	Buy	+506	New	+$222K	0.22%	183
2024 Q3	–	Sell	-926	Closed	-$451K	–	410
2024 Q2	$451K	Sell	926 -424	-31%	-$213K	0.33%	71
2024 Q1	$729K	Buy	+1,350	New	+$738K	0.48%	31
2023 Q4	–	Sell	-877	Closed	-$383K	–	368
2023 Q3	$383K	Buy	877 +213	+32%	+$106K	0.38%	67
2023 Q2	$333K	Sell	664 -133	-17%	-$63.7K	0.33%	92
2023 Q1	$399K	Buy	+797	New	+$381K	0.47%	49
2020 Q4	–	Sell	-612	Closed	-$241K	–	232
2020 Q3	$241K	Buy	+612	New	+$226K	0.12%	224
2020 Q2	–	Sell	-956	Closed	-$232K	–	341
2020 Q1	$232K	Sell	956 -140	-13%	-$36.5K	0.23%	161
2019 Q4	$286K	Buy	+1,096	New	+$289K	0.22%	102

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Olympiad Research's IDXX Position: Q2 2025 in Review

Olympiad Research sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 542 shares — an estimated $228K sold.

Olympiad Research first reported a position in IDXX in Q4 2019 and held it in 10 quarters. The position peaked at $729K in Q1 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

Olympiad Research reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
Olympiad Research sold 542 Idexx Laboratories shares in Q2 2025, an estimated $228K.
Olympiad Research first reported a position in Idexx Laboratories in Q4 2019 and held it in 10 quarters.
Olympiad Research's Idexx Laboratories position peaked at $729K in Q1 2024.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Olympiad Research's 13F filing for Q2 2025, filed 8 Aug 2025.